Data / Drug companies / Pravastatin sodium
Pravastatin sodium: 39 companies and 183 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pravastatin sodium is listed in the FDA National Drug Code Directory by 39 companies, with 183 products in commercial distribution. 183 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated, and the newest product started marketing on September 4, 2026.
The request: Get every company that lists pravastatin sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 39
- Products
- 183
- Generic (ANDA) products
- 183 (100.0%)
- Application numbers
- 10
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list pravastatin sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 25 | tablet | Generic drugs (ANDA) | February 27, 2025 |
| Bryant Ranch Prepack | 15 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Bryant Ranch Prepack | 13 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Preferred Pharmaceuticals Inc. | 8 | tablet | Generic drugs (ANDA) | December 8, 2025 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 7 | tablet | Generic drugs (ANDA) | June 1, 2024 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet | Generic drugs (ANDA) | February 27, 2025 |
| Aurobindo Pharma Limited | 5 | tablet | Generic drugs (ANDA) | September 4, 2026 |
| Remedyrepack Inc. | 5 | tablet | Generic drugs (ANDA) | July 28, 2025 |
| Accord Healthcare Inc. | 4 | tablet | Generic drugs (ANDA) | February 16, 2017 |
| Amici Pharma, Inc. | 4 | tablet | Generic drugs (ANDA) | May 19, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | April 13, 2018 |
| Apotex Corp. | 4 | tablet | Generic drugs (ANDA) | July 18, 2011 |
| Aurobindo Pharma Limited | 4 | tablet | Generic drugs (ANDA) | February 2, 2017 |
| AvPAK | 4 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Biocon Pharma Inc. | 4 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Chartwell RX, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | September 26, 2024 |
| Cipla USA Inc. | 4 | tablet | Generic drugs (ANDA) | June 1, 2024 |
| Direct_Rx | 4 | tablet | Generic drugs (ANDA) | July 29, 2020 |
| Dr. Reddy's Laboratories Limited | 4 | tablet | Generic drugs (ANDA) | December 31, 2009 |
| Glenmark Pharmaceuticals Inc., USA | 4 | tablet | Generic drugs (ANDA) | December 28, 2007 |
| Golden State Medical Supply, Inc. | 4 | tablet | Generic drugs (ANDA) | April 13, 2018 |
| Lupin Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | July 24, 2008 |
| NorthStar Rx LLC | 4 | tablet | Generic drugs (ANDA) | August 12, 2022 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | April 16, 2026 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | February 16, 2017 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | March 2, 2025 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Cardinal Health 107, LLC | 3 | tablet | Generic drugs (ANDA) | July 18, 2011 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | December 8, 2025 |
| Major Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | July 18, 2011 |
| Northwind Health Company, LLC | 3 | tablet | Generic drugs (ANDA) | April 13, 2022 |
| Quallent Pharmaceuticals Health LLC | 3 | tablet | Generic drugs (ANDA) | December 3, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 16, 2017 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | July 18, 2011 |
| Safecor Health, LLC | 2 | tablet | Generic drugs (ANDA) | January 28, 2026 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | January 15, 2019 |
| Quality Care Products LLC | 1 | tablet | Generic drugs (ANDA) | July 18, 2011 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | April 25, 2006 |
| Teva Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | February 9, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 179 | 97.8% |
| Tablet, film coated | 4 | 2.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 183 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| HMG-CoA Reductase Inhibitor | 183 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.